Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DIA vs GSK✓SelectedUSD · GSKDIA vs GSK performance historyLatest closeAs of-1.10%11/18
Stock and ETF performance explorer

DIA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.2%
GSK return
+42.7%
Excess return
+9.6%
Maximum drawdown
-20.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.1%-1.3%+0.2%-0.8%
7D-4.3%-3.1%-1.2%-3.7%
30D-3.3%-0.9%-2.4%-3.2%
3M-5.5%-4.2%-1.4%-4.9%
6M+1.6%-1.6%+3.2%+1.6%
YTD+5.6%+2.6%+3.0%+4.5%
1Y+10.4%+6.2%+4.1%+8.5%
3Y+50.3%+55.0%-4.7%+33.9%
5Y+52.2%+42.8%+9.4%+29.3%
All+52.2%+42.7%+9.6%+29.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling